Sertraline Hydrochloride Tablet
Product Images NDC 69097-835

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 69097-835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (20 mg/mL Bottle Label)

Package Label-principal Display Panel (20 mg/mL Bottle Label)
Label for Sertraline Tablets USP 25 mg by Cipla USA Inc. The label states 30 tablets, prescription only, and instructs pharmacists to dispense the Medication Guide separately. It includes storage instructions, manufacturer and distributor information, a barcode, and placeholders for GTIN, serial number, expiration date, and lot number.*
FDA Label Image

Package Label-20 mg/ml Bottle Label (Sertraline Fig04)

Package Label-20 mg/ml Bottle Label (Sertraline Fig04)
Sertraline Tablets USP 25 mg oral tablets label by Cipla USA Inc. The label indicates 30 tablets per bottle, with the active ingredient sertraline hydrochloride equivalent to 25 mg sertraline per tablet. It includes storage instructions, manufacturer details for Ascent Pharmaceuticals, Inc., and Cipla USA Inc., along with an NDC number 69097-833-02 and barcode.*
FDA Label Image

Package Label-principal Display Panel (50 mg/mL Bottle Label)

Package Label-principal Display Panel (50 mg/mL Bottle Label)
Sertraline Tablets, USP 50 mg oral tablets label showing a 30-tablet count. The label indicates prescription-only status (Rx Only) and includes dosage details, storage instructions, and manufacturer information. The labeler is Cipla USA Inc., with manufacturing by InvaGen Pharmaceuticals, Inc. The label also features a barcode and QR code along with NDC 69097-834-02.*
FDA Label Image

Package Label-50 mg/ml Bottle Label (Sertraline Fig06)

Package Label-50 mg/ml Bottle Label (Sertraline Fig06)
Label for Sertraline Hydrochloride Tablets, USP 50 mg oral tablets from Cipla USA Inc. The label indicates that the package contains 30 tablets. It includes storage instructions, manufacturer details, and a barcode with a QR code. The strength 50 mg is prominently displayed on a green background.*
FDA Label Image

Package Label-principal Display Panel (100 mg/mL Bottle Label)

Package Label-principal Display Panel (100 mg/mL Bottle Label)
Label for Sertraline Tablets USP 100 mg by Cipla USA Inc., containing 30 tablets. The label includes the NDC code 69097-835-02, a note for pharmacists to dispense the Medication Guide, manufacturing information from Invagen Pharmaceuticals, Inc., and storage instructions. It also shows a barcode and a QR code for product identification.*
FDA Label Image

Package Label-100 mg/ml Bottle Label (Sertraline Fig08)

Package Label-100 mg/ml Bottle Label (Sertraline Fig08)
Label for Sertraline Tablets, USP 100 mg oral tablets, containing 30 tablets. The label includes prescription designation (Rx Only), storage instructions, and manufacturer information indicating Ascent Pharmaceuticals, Inc., with Cipla USA Inc. as the labeler. The label shows the NDC number 69097-835-02, a barcode, a QR code, and instructions for pharmacists to dispense the medication guide separately to patients.*
FDA Label Image

Chemical Structure (Sertraline Str)

Chemical Structure (Sertraline Str)
Chemical structure of Sertraline Hydrochloride showing its molecular arrangement with chlorinated aromatic rings and an amine group complexed with hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.